Canaccord said Nature’s Sunshine (NATR) reported Q4 results with Asia proving to be a key region for growth with strong consumer demand as management reconfigured their offering earlier this year to better cater to market demands. China also saw growth in the quarter despite the tougher macro environment. Canaccord reiterated its Buy rating and $21 price target on Nature’s Sunshine shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NATR:
- Nature’s Sunshine Reports Growth Amid Challenges
- Closing Bell Movers: Stitch Fix jumps over 20% on earnings beat, guidance raise
- Nature’s Sunshine reports Q4 EPS 0c, consensus 20c
- Nature’s Sunshine sees FY25 revenue $445M-$470M, consensus $457.14M
- Nature’s Sunshine Products Announces Executive Salary Increases